Because IL-1β and IL-1β-induced genes have been implicated in promoting lung tumor progression in multiple experimental settings and human specimens10,14–16,25, we sought to examine whether IL-1β induced EMT in NSCLC. This evidence concerns the gene IL1B and non-small cell lung carcinoma.